Ovid Therapeutics Inc. - COMMON STOCK (OVID) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2017 to Q4 2025

Type / Class
Equity / COMMON STOCK
Symbol
OVID on Nasdaq
Shares outstanding
130,255,320
Price per share
$1.63
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
36,211,271
Total reported value
$47,075,130
% of total 13F portfolios
0%
Share change
+264,490
Value change
+$6,613,804
Number of holders
80
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Ovid Therapeutics Inc. - COMMON STOCK (OVID) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
RA CAPITAL MANAGEMENT, L.P. 9.9% $19,889,602 13,259,735 RA Capital Management, L.P. 11 Dec 2025
Affinity Asset Advisors, LLC 9% $18,223,749 12,149,166 Affinity Asset Advisors, LLC 11 Dec 2025
TAKEDA PHARMACEUTICAL CO LTD 12% $11,680,055 8,781,996 Takeda Pharmaceutical Company Limited 08 Dec 2025
FEDERATED HERMES, INC. 5.9% $12,611,581 7,737,166 Federated Hermes, Inc. 31 Dec 2025
JANUS HENDERSON GROUP PLC 10% $9,461,772 7,114,114 JANUS HENDERSON GROUP PLC 28 Nov 2025
Point72 Asset Management, L.P. 5.1% $11,099,895 6,727,209 Point72 Asset Management, L.P. 02 Jan 2026
Madison Avenue Partners, LP 4% $969,800 2,852,352 Madison Avenue Partners, LP 31 Dec 2024
BlackRock, Inc. 1.9% $451,636 1,369,010 BlackRock, Inc. 30 Jun 2025
Rubric Capital Management LP 0.67% $153,131 478,533 Rubric Capital Management LP 30 Jun 2025

As of 30 Sep 2025, 80 institutional investors reported holding 36,211,271 shares of Ovid Therapeutics Inc. - COMMON STOCK (OVID). This represents 28% of the company’s total 130,255,320 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Ovid Therapeutics Inc. - COMMON STOCK (OVID) together control 25% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
TAKEDA PHARMACEUTICAL CO LTD 5.8% 7,531,996 0% 60% $9,791,595
VANGUARD GROUP INC 2.2% 2,820,813 +7% 0% $3,667,058
Affinity Asset Advisors, LLC 2% 2,650,000 +297% 0.32% $3,445,000
ACADIAN ASSET MANAGEMENT LLC 1.8% 2,286,505 +8.5% 0.01% $2,971,000
RENAISSANCE TECHNOLOGIES LLC 1.5% 2,018,024 -3.7% 0% $2,623,431
Sio Capital Management, LLC 1.1% 1,427,495 -36% 0.47% $1,855,744
Driehaus Capital Management LLC 1.1% 1,400,191 0% 0.01% $1,820,248
ADAGE CAPITAL PARTNERS GP, L.L.C. 1% 1,350,000 +17% 0% $1,755,000
KENNEDY CAPITAL MANAGEMENT LLC 0.85% 1,106,638 -26% 0.03% $1,438,629
Ikarian Capital, LLC 0.84% 1,095,574 0.32% $1,424,247
MILLENNIUM MANAGEMENT LLC 0.76% 986,293 -6.3% 0% $1,282,181
Assenagon Asset Management S.A. 0.71% 924,576 +112% 0% $1,201,949
Schonfeld Strategic Advisors LLC 0.68% 883,154 0.01% $1,148,098
MARSHALL WACE, LLP 0.6% 783,653 +376% 0% $1,018,751
WELLS FARGO & COMPANY/MN 0.56% 730,716 -4.2% 0% $949,932
GEODE CAPITAL MANAGEMENT, LLC 0.5% 648,020 +0.73% 0% $842,631
Balyasny Asset Management L.P. 0.48% 625,000 0% $812,500
BlackRock, Inc. 0.47% 611,315 -55% 0% $794,710
Walleye Capital LLC 0.46% 596,717 0.01% $775,732
SUSQUEHANNA INTERNATIONAL GROUP, LLP 0.45% 589,094 +156% 0% $765,822
BOOTHBAY FUND MANAGEMENT, LLC 0.37% 486,877 0.02% $632,940
CITADEL ADVISORS LLC 0.31% 405,382 0% $526,997
SIMPLEX TRADING, LLC 0.3% 387,512 0.01% $503,000
BANK OF AMERICA CORP /DE/ 0.28% 362,707 +2333% 0% $471,519
TWO SIGMA INVESTMENTS, LP 0.26% 341,134 0% $443,474

Institutional Holders of Ovid Therapeutics Inc. - COMMON STOCK (OVID) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 660,732 $1,077,331 -$468,555 $1.63 6
2025 Q3 36,211,271 $47,075,130 +$6,613,804 $1.30 80
2025 Q2 35,963,686 $11,861,338 -$3,392,024 $0.33 69
2025 Q1 46,399,305 $14,469,971 -$2,823,886 $0.31 81
2024 Q4 47,565,663 $44,391,185 +$933,718 $0.93 80
2024 Q3 46,326,650 $54,661,169 -$2,312,497 $1.18 75
2024 Q2 46,022,725 $35,395,023 -$20,868,716 $0.77 72
2024 Q1 50,111,416 $152,838,625 -$4,734,653 $3.05 80
2023 Q4 51,658,816 $166,339,097 +$8,163,314 $3.22 77
2023 Q3 42,343,665 $162,598,117 +$5,682,119 $3.84 64
2023 Q2 41,007,449 $134,502,613 +$8,714,482 $3.28 69
2023 Q1 38,694,424 $99,783,463 +$651,350 $2.58 60
2022 Q4 38,559,195 $71,717,529 +$2,582,813 $1.86 58
2022 Q3 35,588,862 $65,480,293 +$1,720,712 $1.84 55
2022 Q2 34,628,854 $74,450,307 -$3,009,412 $2.15 52
2022 Q1 35,130,112 $110,307,198 +$3,432,314 $3.14 61
2021 Q4 34,014,426 $109,179,202 +$1,236,530 $3.21 65
2021 Q3 33,589,442 $112,862,212 -$90,780 $3.36 70
2021 Q2 33,366,478 $130,460,427 -$11,009,099 $3.91 76
2021 Q1 36,251,183 $145,725,613 +$42,574,480 $4.02 85
2020 Q4 27,412,279 $63,321,129 -$6,383,233 $2.31 75
2020 Q3 25,114,493 $144,162,828 +$11,138,040 $5.74 90
2020 Q2 21,848,899 $161,034,711 +$48,530,099 $7.37 78
2020 Q1 15,867,223 $47,289,209 -$7,210,519 $2.98 56
2019 Q4 17,761,607 $73,712,290 +$38,255,959 $4.15 58
2019 Q3 8,206,512 $26,588,025 -$5,121,377 $3.24 37
2019 Q2 10,120,957 $18,724,869 -$3,707,140 $1.85 33
2019 Q1 12,276,773 $21,734,954 +$9,093,088 $1.77 47
2018 Q4 6,835,729 $16,540,605 -$8,205,077 $2.42 46
2018 Q3 7,393,156 $41,919,393 -$3,040,105 $5.67 49
2018 Q2 7,653,221 $59,692,116 +$4,811,013 $7.80 47
2018 Q1 7,048,747 $49,828,303 -$9,279,532 $7.07 48
2017 Q4 7,822,508 $77,212,294 +$5,977,174 $9.87 49
2017 Q3 7,221,932 $61,486,225 -$7,070,486 $8.57 42
2017 Q2 7,991,379 $81,779,560 +$81,779,559 $10.49 43